Vaccine candidate against COVID-19
V-01 is a COVID-19 vaccine candidate developed by a subsidiary of Livzon Pharmaceutical Group Inc.[1][2][3]
References
|
---|
|
|
|
|
|
|
Institutions |
---|
Hospitals and medical clinics | |
---|
Organizations | Global | |
---|
By location | | Health institutes | |
---|
Pandemic institutes | |
---|
Relief funds | |
---|
|
---|
|
---|
|
|
|
Data (templates) |
---|
Global | |
---|
Africa | |
---|
Americas | |
---|
Asia | |
---|
Europe | |
---|
Oceania | |
---|
Others | |
---|
|
|
|
|
---|
Development | |
---|
Classes | |
---|
Administration | |
---|
Vaccines | |
---|
Inventors/ researchers | |
---|
Controversy | |
---|
Related | |
---|
|
|
---|
|
|
|
|
|
|
Institutions |
---|
Hospitals and medical clinics | |
---|
Organizations | Global | |
---|
By location | | Health institutes | |
---|
Pandemic institutes | |
---|
Relief funds | |
---|
|
---|
|
---|
|
|
|
Data (templates) |
---|
Global | |
---|
Africa | |
---|
Americas | |
---|
Asia | |
---|
Europe | |
---|
Oceania | |
---|
Others | |
---|
|
|
|